Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.

BACKGROUND: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies. The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients w...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Hoffmann, L, Jarius, S, Pellkofer, H, Schueller, M, Krumbholz, M, Koenig, F, Johannis, W, la Fougere, C, Newman, T, Vincent, A, Voltz, R
Format: Journal article
Sprog:English
Udgivet: 2008
_version_ 1826258992088743936
author Hoffmann, L
Jarius, S
Pellkofer, H
Schueller, M
Krumbholz, M
Koenig, F
Johannis, W
la Fougere, C
Newman, T
Vincent, A
Voltz, R
author_facet Hoffmann, L
Jarius, S
Pellkofer, H
Schueller, M
Krumbholz, M
Koenig, F
Johannis, W
la Fougere, C
Newman, T
Vincent, A
Voltz, R
author_sort Hoffmann, L
collection OXFORD
description BACKGROUND: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies. The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients with anti-Ma or anti-Ta reactivity, refine the associated clinical picture and review all published patients to date. PATIENTS AND METHODS: Patients were identified by testing for PNMA1 and PNMA2 antibodies by western blotting and indirect immunofluorescence. Clinical data were obtained either by referral of the patient or from the referring physicians. RESULTS: Analysis of 22 new patients (14 anti-Ma, eight anti-Ta) confirmed that anti-Ta are usually found in young men with limbic encephalitis and testicular germ cell tumours who stabilise neurologically with long term survival after tumour treatment. Patients with anti-Ma were of either sex, middle-aged, presented with a range of tumours and neurological symptoms and had a limited response to treatment. Furthermore, we expanded the range of associated clinical features: (1) the peripheral nervous system may be involved; (2) an overlap with anti-Hu is possible; and (3) testicular tumour manifestation can be extragonadal or detectable only at orchiectomy. CONCLUSION: Refining and expanding the range of anti-Ma/anti-Ta associated neurological presentations and tumours clearly demonstrated that the distinction between anti-Ma and anti-Ta associated PNS is of high clinical relevance.
first_indexed 2024-03-06T18:42:49Z
format Journal article
id oxford-uuid:0d79e668-8eff-4063-84a9-2cff3f900a0a
institution University of Oxford
language English
last_indexed 2024-03-06T18:42:49Z
publishDate 2008
record_format dspace
spelling oxford-uuid:0d79e668-8eff-4063-84a9-2cff3f900a0a2022-03-26T09:40:45ZAnti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d79e668-8eff-4063-84a9-2cff3f900a0aEnglishSymplectic Elements at Oxford2008Hoffmann, LJarius, SPellkofer, HSchueller, MKrumbholz, MKoenig, FJohannis, Wla Fougere, CNewman, TVincent, AVoltz, R BACKGROUND: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies. The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients with anti-Ma or anti-Ta reactivity, refine the associated clinical picture and review all published patients to date. PATIENTS AND METHODS: Patients were identified by testing for PNMA1 and PNMA2 antibodies by western blotting and indirect immunofluorescence. Clinical data were obtained either by referral of the patient or from the referring physicians. RESULTS: Analysis of 22 new patients (14 anti-Ma, eight anti-Ta) confirmed that anti-Ta are usually found in young men with limbic encephalitis and testicular germ cell tumours who stabilise neurologically with long term survival after tumour treatment. Patients with anti-Ma were of either sex, middle-aged, presented with a range of tumours and neurological symptoms and had a limited response to treatment. Furthermore, we expanded the range of associated clinical features: (1) the peripheral nervous system may be involved; (2) an overlap with anti-Hu is possible; and (3) testicular tumour manifestation can be extragonadal or detectable only at orchiectomy. CONCLUSION: Refining and expanding the range of anti-Ma/anti-Ta associated neurological presentations and tumours clearly demonstrated that the distinction between anti-Ma and anti-Ta associated PNS is of high clinical relevance.
spellingShingle Hoffmann, L
Jarius, S
Pellkofer, H
Schueller, M
Krumbholz, M
Koenig, F
Johannis, W
la Fougere, C
Newman, T
Vincent, A
Voltz, R
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title_full Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title_fullStr Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title_full_unstemmed Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title_short Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
title_sort anti ma and anti ta associated paraneoplastic neurological syndromes 22 newly diagnosed patients and review of previous cases
work_keys_str_mv AT hoffmannl antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT jariuss antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT pellkoferh antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT schuellerm antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT krumbholzm antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT koenigf antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT johannisw antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT lafougerec antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT newmant antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT vincenta antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases
AT voltzr antimaandantitaassociatedparaneoplasticneurologicalsyndromes22newlydiagnosedpatientsandreviewofpreviouscases